Argenica Therapeutics Limited

ASX:AGN 주식 보고서

시가총액: AU$104.5m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Argenica Therapeutics 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Liz Dallimore

최고 경영자

AU$675.0k

총 보상

CEO 급여 비율37.0%
CEO 임기2.3yrs
CEO 소유권0.04%
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간2.3yrs

최근 관리 업데이트

Recent updates

Companies Like Argenica Therapeutics (ASX:AGN) Are In A Position To Invest In Growth

Jan 12
Companies Like Argenica Therapeutics (ASX:AGN) Are In A Position To Invest In Growth

Argenica Therapeutics (ASX:AGN) Is In A Strong Position To Grow Its Business

Jul 20
Argenica Therapeutics (ASX:AGN) Is In A Strong Position To Grow Its Business

Argenica Therapeutics (ASX:AGN) Is In A Strong Position To Grow Its Business

Apr 20
Argenica Therapeutics (ASX:AGN) Is In A Strong Position To Grow Its Business

We're Not Very Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Rate

Nov 30
We're Not Very Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Rate

Argenica Therapeutics (ASX:AGN) Is In A Good Position To Deliver On Growth Plans

Aug 12
Argenica Therapeutics (ASX:AGN) Is In A Good Position To Deliver On Growth Plans

Here's Why We're Not Too Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Situation

Apr 29
Here's Why We're Not Too Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Situation

Here's Why We're Not Too Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Situation

Dec 30
Here's Why We're Not Too Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Situation

We're Not Very Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Rate

Sep 16
We're Not Very Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Rate

CEO 보상 분석

Liz Dallimore 의 보수는 Argenica Therapeutics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Dec 31 2023n/an/a

-AU$5m

Sep 30 2023n/an/a

-AU$5m

Jun 30 2023AU$675kAU$250k

-AU$5m

Mar 31 2023n/an/a

-AU$4m

Dec 31 2022n/an/a

-AU$4m

Sep 30 2022n/an/a

-AU$4m

Jun 30 2022AU$337kAU$228k

-AU$4m

Mar 31 2022n/an/a

-AU$3m

Dec 31 2021n/an/a

-AU$3m

Sep 30 2021n/an/a

-AU$2m

Jun 30 2021AU$145kAU$31k

-AU$1m

보상 대 시장: Liz 의 총 보상 ($USD 450.27K )은 Australian 시장( $USD 298.77K ).

보상과 수익: 회사가 수익성이 없는 동안 Liz 의 보상이 증가했습니다.


CEO

Liz Dallimore

2.3yrs

테뉴어

AU$674,955

보상

Dr. Liz Dallimore (B. Sc. (Hons), MBA, PhD, GAICD) serves as Chief Executive Officer of Argenica Therapeutics Limited ands serves as its Managing Director and Director since April 4, 2022. She is a researc...


이사회 구성원

이름위치테뉴어보상소유권
Liz Dallimore
CEO, MD & Director2.3yrsAU$674.96k0.040%
A$ 42.3k
Dianne Angus
Non-Executive Chairmanless than a year데이터 없음데이터 없음
Geoffrey Donnan
Member of Clinical Advisory Committeeno data데이터 없음데이터 없음
Terence Budge
Independent Non-Executive Director3.5yrsAU$36.90k0.39%
A$ 412.0k
Elizabeth McCall
Independent Non-Executive Director3.6yrsAU$36.90k0.10%
A$ 105.6k
Paul Bailey
Member of Clinical Advisory Committeeno data데이터 없음데이터 없음
Tim Phillips
Member of Clinical Advisory Committeeno data데이터 없음데이터 없음
David Blacker
Chairman of Clinical Advisory Committeeno data데이터 없음데이터 없음
Jeffery Saver
Member of Clinical Advisory Committee2yrs데이터 없음데이터 없음

2.3yrs

평균 재임 기간

경험이 풍부한 이사회: AGN 의 이사회경험(평균 재직 기간 2.2 년)으로 간주되지 않으므로 새 이사회가 필요합니다.